1. Farooq, A. V. & Shukla, D. Corneal latency and transmission of herpes simplex virus-1. Future Virol. 6, 101–108. https://doi.org/ 10.2217/fvl.10.74 (2011).
2. Takeda, S. et al. Roles played by toll-like receptor-9 in corneal endothelial cells after herpes simplex virus type 1 infection. Invest. Ophthalmol. Vis. Sci. 52, 6729–6736. https://doi.org/10.1167/iovs.11-7805 (2011).
3. Haruki, T. et al. Indoleamine 2,3-dioxygenase 1 in corneal endothelial cells limits herpes simplex virus type 1-induced acquired immune response. Br. J. Ophthalmol. 99, 1435–1442. https://doi.org/10.1136/bjophthalmol-2015-306863 (2015).
4. Miyazaki, D. et al. Corneal endothelial cells activate innate and acquired arm of anti-viral responses after cytomegalovirus infec- tion. Exp. Eye Res. 161, 143–152. https://doi.org/10.1016/j.exer.2017.06.017 (2017).
5. Negishi, H., Taniguchi, T. & Yanai, H. The interferon (IFN) class of cytokines and the IFN regulatory factor (IRF) transcription factor family. Cold Spring Harb. Perspect. Biol. 10, a028423. https://doi.org/10.1101/cshperspect.a028423 (2018).
6. Schiavoni, G., Mattei, F. & Gabriele, L. Type I interferons as stimulators of DC-mediated cross-priming: Impact on anti-tumor response. Front. Immunol. 4, 483. https://doi.org/10.3389/fimmu.2013.00483 (2013).
7. Knuschke, T. et al. Induction of type I interferons by therapeutic nanoparticle-based vaccination is indispensable to reinforce cytotoxic CD8(+) T cell responses during chronic retroviral infection. Front. Immunol. 9, 614. https://doi.org/10.3389/fimmu. 2018.00614 (2018).
8. Jing, L. et al. Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. J. Clin. Invest. 122, 654–673. https://doi.org/10.1172/JCI60556 (2012).
9. Conrady, C. D., Zheng, M., Stone, D. U. & Carr, D. J. CD8+ T cells suppress viral replication in the cornea but contribute to VEGF- C-induced lymphatic vessel genesis. J. Immunol. 189, 425–432. https://doi.org/10.4049/jimmunol.1200063 (2012).
10. Ramsuran, V. et al. Sequence and phylogenetic analysis of the untranslated promoter regions for HLA class I genes. J. Immunol. 198, 2320–2329. https://doi.org/10.4049/jimmunol.1601679 (2017).
11. Kobayashi, K. S. & van den Elsen, P. J. NLRC5: A key regulator of MHC class I-dependent immune responses. Nat. Rev. Immunol. 12, 813–820. https://doi.org/10.1038/nri3339 (2012).
12. Brutkiewicz, R. R. Cell signaling pathways that regulate antigen presentation. J. Immunol. 197, 2971–2979. https://doi.org/10.4049/ jimmunol.1600460 (2016).
13. Honda, K., Takaoka, A. & Taniguchi, T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25, 349–360. https://doi.org/10.1016/j.immuni.2006.08.009 (2006).
14. Odendall, C. & Kagan, J. C. The unique regulation and functions of type III interferons in antiviral immunity. Curr. Opin. Virol. 12, 47–52. https://doi.org/10.1016/j.coviro.2015.02.003 (2015).
15. Jefferies, C. A. Regulating IRFs in IFN driven disease. Front. Immunol. 10, 325. https://doi.org/10.3389/fimmu.2019.00325 (2019).
16. Thompson, M. R., Kaminski, J. J., Kurt-Jones, E. A. & Fitzgerald, K. A. Pattern recognition receptors and the innate immune response to viral infection. Viruses 3, 920–940. https://doi.org/10.3390/v3060920 (2011).
17. Au, W. C., Moore, P. A., LaFleur, D. W., Tombal, B. & Pitha, P. M. Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J. Biol. Chem. 273, 29210–29217. https://doi.org/10.1074/jbc. 273.44.29210 (1998).
18. Civas, A., Island, M. L., Genin, P., Morin, P. & Navarro, S. Regulation of virus-induced interferon-A genes. Biochimie 84, 643–654. https://doi.org/10.1016/s0300-9084(02)01431-1 (2002).
19. Osterlund, P. I., Pietila, T. E., Veckman, V., Kotenko, S. V. & Julkunen, I. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J. Immunol. 179, 3434–3442. https://doi.org/10.4049/jimmunol.179.6.3434 (2007).
20. Iversen, M. B. & Paludan, S. R. Mechanisms of type III interferon expression. J. Interferon Cytokine Res. 30, 573–578. https://doi. org/10.1089/jir.2010.0063 (2010).
21. Andersen, L. L. et al. Functional IRF3 deficiency in a patient with herpes simplex encephalitis. J. Exp. Med. 212, 1371–1379. https:// doi.org/10.1084/jem.20142274 (2015).
22. Canivet, C. et al. Both IRF3 and especially IRF7 play a key role to orchestrate an effective cerebral inflammatory response in a mouse model of herpes simplex virus encephalitis. J. Neurovirol. 24, 761–768. https://doi.org/10.1007/s13365-018-0666-9 (2018).
23. Chen, H. W. et al. The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus. J. Immunol. 191, 4194–4201. https://doi.org/10.4049/jimmunol.1300799 (2013).
24. Li, W., Hofer, M. J., Nocon, A. L., Manders, P. & Campbell, I. L. Interferon regulatory factor 7 (IRF7) is required for the optimal initial control but not subsequent clearance of lymphocytic choriomeningitis virus infection in mice. Virology 439, 152–162. https:// doi.org/10.1016/j.virol.2013.02.015 (2013).
25. Ciancanelli, M. J. et al. Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 defi- ciency. Science 348, 448–453. https://doi.org/10.1126/science.aaa1578 (2015).
26. Channappanavar, R. et al. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J. Clin. Invest. 129, 3625–3639. https://doi.org/10.1172/JCI126363 (2019).
27. Ziegler, C. G. K. et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181, 1016–1035. https://doi.org/10.1016/j.cell.2020.04.035 (2020).
28. Sugita, S. et al. Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism. Invest. Ophthalmol. Vis. Sci. 50, 263–272. https://doi.org/10.1167/iovs.08-2536 (2009).
29. Yamada, Y., Sugita, S., Horie, S., Yamagami, S. & Mochizuki, M. Mechanisms of immune suppression for CD8+ T cells by human corneal endothelial cells via membrane-bound TGFbeta. Invest. Ophthalmol. Vis. Sci. 51, 2548–2557. https://doi.org/10.1167/iovs. 09-4233 (2010).
30. Miyazaki, D. et al. Herpes simplex virus type 1-induced transcriptional networks of corneal endothelial cells indicate antigen presentation function. Invest. Ophthalmol. Vis. Sci. 52, 4282–4293. https://doi.org/10.1167/iovs.10-6911 (2011).
31. Antonczyk, A. et al. Direct inhibition of IRF-dependent transcriptional regulatory mechanisms associated with disease. Front. Immunol. 10, 1176. https://doi.org/10.3389/fimmu.2019.01176 (2019).